Taiwanese research announces the dawn of CELL, one liter of rare tears

0 views
0%

[New Tang Dynasty Asia Pacific Channel, February 23, 2012]Looking at new breakthroughs in the field of biomedicine, the well-known scientific journal CELL published a study at Yangming University in Taiwan and discovered the key mechanism of hereditary dementia, giving a glimmer of hope for the development of new drugs. If the onset can be successfully delayed in the future, then the story of the protagonist, such as a litre of tears in a Japanese drama, and a movie with a scene, can be rewritten. With a litre of tears in the Japanese drama, the protagonist Ya also bravely faced the story of cerebellar atrophy, which is exciting. He became onset at the age of 15 and died at the age of 25, and his motor coordination was gradually lost, and the medical profession was helpless. However, the latest CELL journal published a study by Yangming University in Taiwan and found that the transcription elongation factor Spt4 in human genes is the key to the expression of human dementia mutant genes and the apoptosis of brain cells. As long as Spt4 is inhibited, there is a chance to delay Onset. Zheng Zihao, Associate Professor of the Studentization and Separation Institute of Yangming University: “There is already such a mutant gene in it, so basically, unless you change the entire DNA, but it is unlikely that you can only change the situation. This process can be delayed, that is to say, the time of its onset is shifted.” After the Spt4 mechanism is discovered, if the target new drug is successfully developed, not only cerebellar atrophy, including Huntington’s disease, etc., Patients with nine kinds of dementia diseases are expected to benefit. The achievements made by the Taiwanese research team for eight years have also allowed international medical development to break through. NTDTV Asia Pacific Television Chen Jinjiao Chen Zhen, Taiwan Taipei Report-This article is reproduced from http://ap.ntdtv.com/news/20120223/video/88847.html-For more videos, welcome to “NTDTV Official Website” http:/ /ap.ntdtv.com Other recommendations: “Shen Yun” and “SHEN YUN” http://ShenYun2012.com/ Watch the dynamic network: Xiaotianxiashi http://www.dongtaiwang.com/ Shen Yun opens Mississauga’s horizons http: //www.ntdtv.com/xtr/b5/2012/01/20/a649406.html.

source

From:
Date: December 14, 2020

[New Tang Dynasty Asia Pacific Channel, February 23, 2012]Looking at new breakthroughs in the field of biomedicine, the well-known scientific journal CELL published a study at Yangming University in Taiwan and discovered the key mechanism of hereditary dementia, giving a glimmer of hope for the development of new drugs. If the onset can be successfully delayed in the future, then the story of the protagonist, such as a litre of tears in a Japanese drama, and a movie with a scene, can be rewritten. With a litre of tears in the Japanese drama, the protagonist Ya also bravely faced the story of cerebellar atrophy, which is exciting. He became onset at the age of 15 and died at the age of 25, and his motor coordination was gradually lost, and the medical profession was helpless. However, the latest CELL journal published a study by Yangming University in Taiwan and found that the transcription elongation factor Spt4 in human genes is the key to the expression of human dementia mutant genes and the apoptosis of brain cells. As long as Spt4 is inhibited, there is a chance to delay Onset. Zheng Zihao, Associate Professor of the Studentization and Separation Institute of Yangming University: "There is already such a mutant gene in it, so basically, unless you change the entire DNA, but it is unlikely that you can only change the situation. This process can be delayed, that is to say, the time of its onset is shifted." After the Spt4 mechanism is discovered, if the target new drug is successfully developed, not only cerebellar atrophy, including Huntington’s disease, etc., Patients with nine kinds of dementia diseases are expected to benefit. The achievements made by the Taiwanese research team for eight years have also allowed international medical development to break through. NTDTV Asia Pacific Television Chen Jinjiao Chen Zhen, Taiwan Taipei Report-This article is reproduced from http://ap.ntdtv.com/news/20120223/video/88847.html-For more videos, welcome to "NTDTV Official Website" http:/ /ap.ntdtv.com Other recommendations: "Shen Yun" and "SHEN YUN" http://ShenYun2012.com/ Watch the dynamic network: Xiaotianxiashi http://www.dongtaiwang.com/ Shen Yun opens Mississauga's horizons http: //www.ntdtv.com/xtr/b5/2012/01/20/a649406.html.
source">
[New Tang Dynasty Asia Pacific Channel, February 23, 2012]Looking at new breakthroughs in the field of biomedicine, the well-known scientific journal CELL published a study at Yangming University in Taiwan and discovered the key mechanism of hereditary dementia, giving a glimmer of hope for the development of new drugs. If the onset can be successfully delayed in the future, then the story of the protagonist, such as a litre of tears in a Japanese drama, and a movie with a scene, can be rewritten. With a litre of tears in the Japanese drama, the protagonist Ya also bravely faced the story of cerebellar atrophy, which is exciting. He became onset at the age of 15 and died at the age of 25, and his motor coordination was gradually lost, and the medical profession was helpless. However, the latest CELL journal published a study by Yangming University in Taiwan and found that the transcription elongation factor Spt4 in human genes is the key to the expression of human dementia mutant genes and the apoptosis of brain cells. As long as Spt4 is inhibited, there is a chance to delay Onset. Zheng Zihao, Associate Professor of the Studentization and Separation Institute of Yangming University: "There is already such a mutant gene in it, so basically, unless you change the entire DNA, but it is unlikely that you can only change the situation. This process can be delayed, that is to say, the time of its onset is shifted." After the Spt4 mechanism is discovered, if the target new drug is successfully developed, not only cerebellar atrophy, including Huntington’s disease, etc., Patients with nine kinds of dementia diseases are expected to benefit. The achievements made by the Taiwanese research team for eight years have also allowed international medical development to break through. NTDTV Asia Pacific Television Chen Jinjiao Chen Zhen, Taiwan Taipei Report-This article is reproduced from http://ap.ntdtv.com/news/20120223/video/88847.html-For more videos, welcome to "NTDTV Official Website" http:/ /ap.ntdtv.com Other recommendations: "Shen Yun" and "SHEN YUN" http://ShenYun2012.com/ Watch the dynamic network: Xiaotianxiashi http://www.dongtaiwang.com/ Shen Yun opens Mississauga's horizons http: //www.ntdtv.com/xtr/b5/2012/01/20/a649406.html.
source&source=https://vidnews.co.uk">




Leave a Reply

Your email address will not be published. Required fields are marked *